Vice President of Product Management, Freenome
$293.6-383.8k
+ Equity, cash bonuses
Office located in Brisbane, CA
Biological analysis platform for cancer
Be an early applicant
Biological analysis platform for cancer
501-1000 employees
Be an early applicant
$293.6-383.8k
+ Equity, cash bonuses
Office located in Brisbane, CA
501-1000 employees
Company mission
To create tools that empower everyone to prevent, detect, and treat their disease.
Role
Who you are
- Bachelor's degree in Business, Marketing, Engineering, or a related field; Master's degree preferred
- Minimum of 15 years of progressive experience in product management; management consulting experience a plus
- Minimum of 10 years leadership experience building and cultivating high-performing teams
- Prior oncology, primary care, and consumer experience
- Prior in vitro diagnostic product launch experience
- Strong understanding of the diagnostics market, including regulatory and compliance landscape, competitive dynamics and customer and patient behavior
- Proven track record of developing and launching successful products in a competitive market
- Strong understanding of customer experience principles and methodologies, with experience leading customer-centric initiatives
- Excellent leadership and team-building skills, with the ability to inspire and motivate cross-functional teams
- Strong analytical and problem-solving skills, with a data-driven approach to decision-making
- Exceptional communication and interpersonal skills, with the ability to engage and influence stakeholders at all levels
- Willingness to travel as needed to meet with customers, partners, and teams
What the job involves
- The Vice President of Product Management will own the development and execution of Freenome’s product portfolio roadmap across three verticals: assay development, digital health, and the data platform
- Working in close partnership with leaders across the company, this individual will translate clinical, scientific, customer, and business needs into a cohesive product strategy enabled by AI/agents that supports early cancer detection and patient access
- In assay development, this role will define product requirements and roadmap priorities for Freenome's diagnostic tests and test versioning through assay enhancements and AI
- Across digital health, this leader will define the product experiences and workflows for patients, providers, and internal operations, with a focus on usability, access, and adoption
- For the data platform, this role will lead defining capabilities, analytics, and data products needed to connect biological, clinical, and customer insights to portfolio decisions and product performance
- The role reports to the Chief Product Officer. As a member of the Senior Leadership Team, you will contribute to guiding and refining company-level strategy
- Our commitment to patient care and access will significantly contribute to our growth and our mission to outpace cancer with early detection. This role will be a hybrid role based in our Brisbane, California headquarters
- Define, lead, develop, and implement the Freenome product roadmap with deep AI/agent integration and strategy in partnership with the Senior Leadership Team and Chief Product Officer that meets personalized care portfolio objectives
- Lead a team of product managers and technical product managers, inspiring the team with a clear vision and direction to enable excellence in execution, innovation, and collaboration
- Coach and develop a multi-disciplinary team, fostering a culture of continuous learning and growth
- Develop and implement comprehensive product strategies, including market analysis, product development, and lifecycle management
- Lead and influence through deep clinical and scientific market understanding to guide effective product portfolio and development priorities
- Own the overall product portfolio roadmap through organizational alignment of competing dynamics in science, commercial, regulatory, market access, clinical pathways, and patient preferences
- Own and lead decision making forums that prioritize and define R&D and product pipelines aligned with company strategy and objectives
- Drive product decisions and priorities using strategic frameworks and quantitative analyses
- Architects and integrates AI automation, agentic workflows and enablement strategies for Freenome’s product roadmap
- Establish and maintain relationships with key customers and partners, gathering feedback and insights to inform product development and improvement
- Monitor and analyze market trends, competitor activities, and customer feedback to identify opportunities for product innovation and enhancement
- Define and track key performance indicators (KPIs) for product performance and customer satisfaction, using data to drive decision-making and continuous improvement
- Represent the company at industry events, conferences, and in the media, serving as a thought leader in product management
Our take
Freenome is a biotechnology company offering a biological analysis platform that uses molecular biology and machine learning to detect cancer with a routine blood draw. The platform trains on thousands of cancer-positive blood samples to recognise disease-associated patterns and help detect early-stage cancer, allowing clinicians to optimise treatments.
The company specialises in advanced computational biology, using machine learning to detect patterns among billions of circulating cell-free biomarkers. Freenome continues to focus on the development of its colorectal cancer test, potentially helping the 45 million people not currently up-to-date on colorectal cancer screening guidelines in the United States.
Following its 2022 funding round, the company surpassed the $1 billion funding mark. Freenome is set to accelerate the development of its platform, testing for additional cancers and furthering its blood test detection technology. It's also forming partnerships for R&D purposes, joining forces with health firms such as Geisinger to provide real-world data that could help it detect multiple cancers.
Steph
Company Specialist at Welcome to the Jungle
Insights
14% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Nov 2025
$75m
LATE VC
Feb 2024
$254m
LATE VC
Total funding: $1.1bn
Company HQ
The East Side, South San Francisco, CA
Leadership
Riley Ennis
(Co-Founder)Studied at Yale, Johns Hopkins and Dartmouth. Was a Thiel Fellow and co-founded Immudicon and Oncolinx.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 8 more jobs at Freenome